Literature DB >> 6161176

Antigen-specific human T cell factors. II. T cell suppressor factor: biologic properties.

F Uytdehaag, C J Heijnen, K H Pot, R E Ballieux.   

Abstract

The in vitro induction of an ovalbumin-specific human T cell suppressor factor is described (TsF120-OA). The antigen-specific suppressive component can be purified by affinity chromatography from supernatants derived from Marbrook-Diener type cultures of peripheral blood T cells stimulated with a high dose of ovalbumin. TsF120-OA suppresses the antigen-induced PFC formation of human blood B cells in vitro in an antigen-specific way. The target of TsF120-OA activity is shown to be the T helper cell. No genetic restriction in the action of the factor is observed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161176

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Specific suppression of anti-DNA production in vitro.

Authors:  M R Liebling; C Wong; J Radosevich; J S Louie
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

2.  T cells in B cell chronic lymphocytic leukaemia. I. Decreased frequency of T lymphocytes secreting suppressor factor.

Authors:  A C Bloem; J C Clevers; E J Bast; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

3.  The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.

Authors:  C R Crawford; R Jennings; N Bradford; C W Potter
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

Review 4.  Human nonspecific suppressive lymphokines.

Authors:  M T Halpern
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

5.  A non-specific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production.

Authors:  G Lombardi; D Vismara; E Piccolella; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

6.  Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

Authors:  J Laurence; A B Gottlieb; H G Kunkel
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

7.  Immunoglobulin production after marrow transplantation. III. The functional heterogeneity of FC-IgG receptor positive and negative T cell subpopulations.

Authors:  L G Lum; M C Seigneuret; N Orcutt-Thordarson; R C Ostenson; R Storb
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

Review 8.  Signaling pathways of EBV-induced oncogenesis.

Authors:  Yin Luo; Yitong Liu; Chengkun Wang; Runliang Gan
Journal:  Cancer Cell Int       Date:  2021-02-06       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.